Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Stanford Health Care Center for Memory Disorders is encouraged that there is a new treatment option for certain patients with Alzheimer’s disease. On January 6, 2023, the FDA granted accelerated approval for lecanemab (LeqembiTM).
Your doctor will do a number of tests to make sure your symptoms are caused by Alzheimer's disease and not another condition.
Your doctor will ask about your past health and do a physical exam. The doctor may ask you to do some simple things that test your memory and other mental skills. Your doctor may also check how well you can do daily tasks.
The exam usually includes blood tests to look for another cause of your problems. You may have tests such as CT scans and MRI scans, which look at your brain. By themselves, these tests can't show for sure whether you have Alzheimer's.
It usually is helpful to bring a family member or someone else you trust to the appointment. A family member may be able to provide the best information about how your day-to-day functioning, memory, and personality have changed.
Open trials refer to studies currently recruiting participants or that may recruit participants in the near future. Closed trials are not currently enrolling, but similar studies may open in the future.
Closed trials are not currently enrolling, but may open in the future.